CIK 0001681682
- Non-accelerated filer
- Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 260579295
- Phone
- +1 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Technology Officer sold 33,750 shares at an average $2.44 ($82,388)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Commercial Officer sold 20,000 shares at an average $1.08 ($21,685)
- 4 Open-market sale Chief Commercial Officer sold 8,731 shares at $0.94 ($8,207)
- 4 Open-market sale Director sold 10,000 shares at $0.90 ($9,000)
- 4 Open-market sale Chief Commercial Officer sold 11,269 shares at $0.94 ($10,593)
- 4 Open-market sale Chief Financial Officer sold 35,000 shares at $0.90 ($31,500)
- 4 Open-market sale Chief Commercial Officer sold 25,000 shares at $0.73 ($18,250)
- 4 Open-market sale Chief Executive Officer sold 71,519 shares at $0.83 ($59,361)
- 4 Open-market sale Chief Commercial Officer sold 10,000 shares at $0.81 ($8,100)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Commercial Officer sold 10,000 shares at $0.72 ($7,200)
- 4 Option exercise Director acquired 100,503 shares (option exercise)
- 4 Option exercise Chief Technology Officer acquired 26,000 shares (option exercise)
- 4 Option exercise Director acquired 5,000 shares (option exercise)
Page 4 of 9 · 174 filings